In a recent presentation at the 25th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress, Catherine Gray, the Director of the Office of Prescription Drug Promotion (OPDP) at the FDA, outlined significant regulatory updates affecting the way prescription drugs are advertised directly to consumers. Her talk focused on the recent…